History
Clinicians should suspect AAS use in a muscular man who presents with concerns of infertility, gynaecomastia, or evaluation for testosterone supplementation; or a hirsute, muscular woman who reports amenorrhea.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
AAS use is most common in male athletes.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
The practice is more prevalent among participants in competitive sport, particularly power sports such as bodybuilding, powerlifting, and weightlifting.[28]Sagoe D, Andreassen CS, Pallesen S. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy. 2014 Jul 2;9:27.
https://www.doi.org/10.1186/1747-597X-9-27
http://www.ncbi.nlm.nih.gov/pubmed/24984881?tool=bestpractice.com
The practice is also widespread among participants in many other competitive sports.[6]Thirumalai A, Anawalt BD. Androgenic steroids use and abuse: past, present, and future. Urol Clin North Am. 2022 Nov;49(4):645-63.
http://www.ncbi.nlm.nih.gov/pubmed/36309421?tool=bestpractice.com
[7]Buckman JF, Farris SG, Yusko DA. A national study of substance use behaviors among NCAA male athletes who use banned performance enhancing substances. Drug Alcohol Depend. 2013 Jul 1;131(1-2):50-5.
http://www.ncbi.nlm.nih.gov/pubmed/23688842?tool=bestpractice.com
[28]Sagoe D, Andreassen CS, Pallesen S. The aetiology and trajectory of anabolic-androgenic steroid use initiation: a systematic review and synthesis of qualitative research. Subst Abuse Treat Prev Policy. 2014 Jul 2;9:27.
https://www.doi.org/10.1186/1747-597X-9-27
http://www.ncbi.nlm.nih.gov/pubmed/24984881?tool=bestpractice.com
A history of muscle dysmorphia or other body image disorder is a key risk factor.[31]Pope HG Jr, Khalsa JH, Bhasin S. Body image disorders and abuse of anabolic-androgenic steroids among men. JAMA. 2017 Jan 3;317(1):23-4.
http://www.ncbi.nlm.nih.gov/pubmed/27930760?tool=bestpractice.com
Many people who use AASs do not seek medical advice or treatment for health conditions potentially associated with the use of AASs.[37]Amaral JMX, Kimergård A, Deluca P. Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open. 2022 Jul 4;12(7):e056445.
https://www.doi.org/10.1136/bmjopen-2021-056445
http://www.ncbi.nlm.nih.gov/pubmed/35788077?tool=bestpractice.com
Users will often live with numerous cosmetic, endocrine, and hepatic toxicities, seeking help only if these seem worse than coaches or peers told them to expect, or if symptoms do not abate after decreasing or stopping their AAS use.
The most useful tool for diagnosis is to ask about the use of AASs in a non-judgemental way.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023.
http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
A suggested approach is to ask about the frequency and intensity of training sessions, the goals of such training, their perceptions of their body image, and if they have been offered or used steroids.[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501.
https://www.doi.org/10.1210/endrev/bnab001
http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
In those who state that they use AASs, attempt to establish the substances involved and duration and pattern of use, including mode of administration.[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023.
http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
Psychiatric and neurological symptoms
Psychiatric symptoms (mania, hypomania, depression, aggression, cognitive deficits) are common. However, the potential confounding effects of other illicit substance use and prior psychiatric history need to be considered.[6]Thirumalai A, Anawalt BD. Androgenic steroids use and abuse: past, present, and future. Urol Clin North Am. 2022 Nov;49(4):645-63.
http://www.ncbi.nlm.nih.gov/pubmed/36309421?tool=bestpractice.com
[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501.
https://www.doi.org/10.1210/endrev/bnab001
http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
People with a narcissistic personality disorder may be more prone to use AASs.[39]Piacentino D, Sani G, Kotzalidis GD, et al. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings. Hum Psychopharmacol. 2022 Jan;37(1):e2815.
https://www.doi.org/10.1002/hup.2815
http://www.ncbi.nlm.nih.gov/pubmed/34528289?tool=bestpractice.com
AASs in supraphysiological concentrations influence several central nervous system functions, such as memory, aggressiveness, anxiety, and depression, particularly in predisposed individuals.[40]Albano GD, Amico F, Cocimano G, et al. Adverse effects of anabolic-androgenic steroids: a literature review. Healthcare (Basel). 2021 Jan 19;9(1):97.
https://www.doi.org/10.3390/healthcare9010097
http://www.ncbi.nlm.nih.gov/pubmed/33477800?tool=bestpractice.com
There seems to be a dose-related effect of AAS use on mood disorders, with very high dosages of AASs causing manic symptoms in normal men.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
[41]Onakomaiya MM, Henderson LP. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology (Berl). 2016 Feb;233(4):549-69.
http://www.ncbi.nlm.nih.gov/pubmed/26758282?tool=bestpractice.com
‘Roid rage' is the classic lay term to describe aggressive behaviour that is seemingly due to AAS use.[2]Ding JB, Ng MZ, Huang SS, et al. Anabolic-androgenic steroid misuse: mechanisms, patterns of misuse, user typology, and adverse effects. J Sports Med (Hindawi Publ Corp). 2021 Dec 10;2021:7497346.
https://www.doi.org/10.1155/2021/7497346
http://www.ncbi.nlm.nih.gov/pubmed/34926695?tool=bestpractice.com
Take a detailed drug history
Many people with AAS use disorder also use other drugs to alleviate the negative effects associated with AAS use, so a full drug history should be taken:[2]Ding JB, Ng MZ, Huang SS, et al. Anabolic-androgenic steroid misuse: mechanisms, patterns of misuse, user typology, and adverse effects. J Sports Med (Hindawi Publ Corp). 2021 Dec 10;2021:7497346.
https://www.doi.org/10.1155/2021/7497346
http://www.ncbi.nlm.nih.gov/pubmed/34926695?tool=bestpractice.com
[42]Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014 Jun;35(3):341-75.
https://www.doi.org/10.1210/er.2013-1058
http://www.ncbi.nlm.nih.gov/pubmed/24423981?tool=bestpractice.com
Aromatase inhibitors (e.g., anastrozole) are used to prevent the conversion of testosterone to estradiol
Anti-oestrogens (tamoxifen) are used to block oestrogen receptors
Clomiphene/human chorionic gonadotrophin (hCG) are taken to prevent testicular atrophy and infertility
PDE-5 inhibitors (sildenafil, tadalafil) for sexual dysfunction (low libido, erectile dysfunction)
Furosemide is used to treat oedema
Anxiolytics are used to prevent anxiety
Acne medications are used to treat acne and oily skin
Nutritional supplements (e.g., protein, creatine), used by many bodybuilders and athletes
Probenecid and epitestosterone may be used to mask AAS detection.
AAS dependence
On cessation of AAS use, users may feel depressed, fatigued, unable to concentrate, and suicidal.[6]Thirumalai A, Anawalt BD. Androgenic steroids use and abuse: past, present, and future. Urol Clin North Am. 2022 Nov;49(4):645-63.
http://www.ncbi.nlm.nih.gov/pubmed/36309421?tool=bestpractice.com
The euphoric effects of AAS use and the dysphoric effects of withdrawal may contribute to dependence in some people.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
Physical examination
Body composition and muscularity (including height, weight, and body mass index) should be noted and compared with previous measurements, if available. Adolescents who use AASs may have short stature due to closure of the epiphyseal plates.[21]Casavant MJ, Blake K, Griffith J, et al. Consequences of use of anabolic androgenic steroids. Pediatr Clin North Am. 2007 Aug;54(4):677-90, x.
http://www.ncbi.nlm.nih.gov/pubmed/17723870?tool=bestpractice.com
In most people, regular doses of AAS will produce well-recognised physical changes:[19]Handelsman DJ. Androgen misuse and abuse. Endocr Rev. 2021 Jul 16;42(4):457-501.
https://www.doi.org/10.1210/endrev/bnab001
http://www.ncbi.nlm.nih.gov/pubmed/33484556?tool=bestpractice.com
In men: acne, oily skin, muscular development, changes in libido, testicular atrophy, erectile dysfunction, infertility, temporal hairline recession, and gynaecomastia.
In women: acne, oily skin, muscular development, menstrual irregularities, and changes in libido. The potential irreversible masculinising effects include hirsutism, male pattern baldness, deepening of the voice, and clitoral hypertrophy.[20]American College of Obstetricians and Gynecologists. ACOG committee opinion no. 484 (reaffirmed 2021): performance enhancing anabolic steroid abuse in women. Obstet Gynecol. 2011 Apr;117(4):1016-8.
https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2011/04/performance-enhancing-anabolic-steroid-abuse-in-women
http://www.ncbi.nlm.nih.gov/pubmed/21422881?tool=bestpractice.com
Clinical features related to chronic use are varied and depend on the body system affected.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
[2]Ding JB, Ng MZ, Huang SS, et al. Anabolic-androgenic steroid misuse: mechanisms, patterns of misuse, user typology, and adverse effects. J Sports Med (Hindawi Publ Corp). 2021 Dec 10;2021:7497346.
https://www.doi.org/10.1155/2021/7497346
http://www.ncbi.nlm.nih.gov/pubmed/34926695?tool=bestpractice.com
[42]Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014 Jun;35(3):341-75.
https://www.doi.org/10.1210/er.2013-1058
http://www.ncbi.nlm.nih.gov/pubmed/24423981?tool=bestpractice.com
Dermatological
Temporal hairline recession
Striae or keloids
Needle marks
Signs of cellulitis or skin abscess (e.g., local swelling, fluctuance, hardening of the tissue, red open [or closed] sore that may be draining fluid, fever).
Endocrine
Testicular atrophy, prostatic enlargement, and gynaecomastia in males
Clitoral hypertrophy in females
Premature masculinisation/feminisation in adolescents who use AASs.
Psychiatric
Aggressive behaviour is common
Anxiety, mania, depression, psychosis, or tics may indicate psychiatric complications.
Cardiovascular/hepatic
Laboratory investigations
In professional athletes, World Anti-Doping Agency compliant testing of urinary and serum testosterone, dihydrotestosterone, epitestosterone, and their precursors is undertaken at baseline (before the athlete's first competition that has anti-doping regulations) and is followed longitudinally.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
The specimen should be obtained under direct observation. The test may be of limited value, as an experienced athlete is likely to be aware of methods of hiding or masking drug use.
The ratio of testosterone to epitestosterone (T/E ratio) should be ordered, as gas chromatography with mass spectrometry cannot distinguish between endogenous and exogenous testosterone. Patients taking exogenous testosterone will have a higher T/E ratio.
There is no practical diagnostic test to detect AAS use in the general population.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
Because AASs suppress circulating gonadotrophin concentrations, the most useful of the commonly available tests are measurements of serum testosterone, follicle-stimulating hormone, and luteinising hormone concentrations.[1]Anawalt BD. Diagnosis and management of anabolic androgenic steroid use. J Clin Endocrinol Metab. 2019 Jul 1;104(7):2490-500.
https://www.doi.org/10.1210/jc.2018-01882
http://www.ncbi.nlm.nih.gov/pubmed/30753550?tool=bestpractice.com
Indirect markers of anabolic-androgenic steroid use
If AAS use is suspected, consider the following investigations:[6]Thirumalai A, Anawalt BD. Androgenic steroids use and abuse: past, present, and future. Urol Clin North Am. 2022 Nov;49(4):645-63.
http://www.ncbi.nlm.nih.gov/pubmed/36309421?tool=bestpractice.com
[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023.
http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
[43]Christou GA, Christou MA, Žiberna L, et al. Indirect clinical markers for the detection of anabolic steroid abuse beyond the conventional doping control in athletes. Eur J Sport Sci. 2019 Oct;19(9):1276-86.
http://www.ncbi.nlm.nih.gov/pubmed/30880613?tool=bestpractice.com
Needle sharing places patients at risk for contracting infectious diseases. Therefore, patients should be routinely tested for viral hepatitis and HIV.[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023.
http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
[42]Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014 Jun;35(3):341-75.
https://www.doi.org/10.1210/er.2013-1058
http://www.ncbi.nlm.nih.gov/pubmed/24423981?tool=bestpractice.com
An ECG and echocardiogram may be warranted if cardiovascular complications are suspected (i.e., if dyspnoea, palpitations, syncope, murmur, or chest pain is present).[38]Brooks JH, Ahmad I, Easton G. Anabolic steroid use. BMJ. 2016 Oct 13;355:i5023.
http://www.ncbi.nlm.nih.gov/pubmed/27737851?tool=bestpractice.com
Nuclear medicine imaging modalities may facilitate improved diagnosis of cardiovascular pathology.[44]Baggish AL, Weiner RB, Kanayama G, et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017 May 23;135(21):1991-2002.
https://www.doi.org/10.1161/CIRCULATIONAHA.116.026945
http://www.ncbi.nlm.nih.gov/pubmed/28533317?tool=bestpractice.com
[45]Luijkx T, Velthuis BK, Backx FJ, et al. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol. 2013 Aug 10;167(3):664-8.
https://www.doi.org/10.1016/j.ijcard.2012.03.072
http://www.ncbi.nlm.nih.gov/pubmed/22459398?tool=bestpractice.com
[46]Baumann S, Jabbour C, Huseynov A, et al. Myocardial scar detected by cardiovascular magnetic resonance in a competitive bodybuilder with longstanding abuse of anabolic steroids. Asian J Sports Med. 2014 Dec;5(4):e24058.
https://www.doi.org/10.5812/asjsm.24058
http://www.ncbi.nlm.nih.gov/pubmed/25741416?tool=bestpractice.com
[47]Golestani R, Slart RH, Dullaart RP, et al. Adverse cardiovascular effects of anabolic steroids: pathophysiology imaging. Eur J Clin Invest. 2012 Jul;42(7):795-803.
http://www.ncbi.nlm.nih.gov/pubmed/22299602?tool=bestpractice.com